Veramyst FDA Approval History
FDA Approved: Yes (Discontinued) (First approved April 27, 2007)
Brand name: Veramyst
Generic name: fluticasone furoate
Dosage form: Nasal Spray
Treatment for: Allergic Rhinitis
Marketing Status: DiscontinuedVeramyst (fluticasone furoate) is an intranasal corticosteroid administered once-daily for the treatment of seasonal and year- round allergy symptoms in adults and children two years of age and older.
On August 2, 2016, the FDA announced the approval of Flonase Sensimist Allergy Relief (fluticasone furoate, 27.5 mcg spray) as an over-the-counter (OTC) replacement for the prescription product Veramyst.
Development Timeline for Veramyst
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.